Mika Sumi,Fumiko Ogino,Toshikazu Kamiya,Masahiko Nakano,Kazutoshi Kikkawa
申请号：
US12440807
公开号：
US08097635B2
申请日:
2007.09.19
申请国别(地区):
US
年份:
2012
代理人:
摘要：
An object of the present invention is to provide a safe and highly effective insulin resistance improving agent or therapeutic agent for type II diabetes. According to the present invention, an insulin resistance improving agent or a therapeutic agent for type II diabetes comprising a compound represented by general formula (I)(wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient can be provided.
